
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2010-10-2509:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-10-095509 |
| 2010-10-0416:46 ET | DEF 14A | Proxy statementPeriod 2010-11-07 | 0000950123-10-091152 |
| 2010-09-1310:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-10-085541 |
| 2010-09-0713:27 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-084127 |
| 2010-08-3006:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-081990 |
| 2010-08-1608:00 ET | 8-K | 8.01 Other events | 0000950123-10-077656 |
| 2010-08-0516:30 ET | 10-Q | Quarterly reportPeriod 2010-06-30 | 0000950123-10-073394 |
| 2010-07-1310:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-065071 |
| 2010-07-1208:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-064750 |
| 2010-06-0808:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-056482 |
| 2010-05-1816:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-050815 |
| 2010-05-1016:30 ET | 10-Q | Quarterly reportPeriod 2010-03-31 | 0000950123-10-047206 |
| 2010-04-2716:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-038864 |
| 2010-03-1707:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-025421 |
| 2010-03-0917:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-022638 |
| 2010-03-0309:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-020348 |
| 2010-02-2620:15 ET | 10-K | Annual reportPeriod 2009-12-31 | 0000950123-10-017277 |
| 2010-02-1110:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-011323 |
| 2010-02-0507:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-009028 |
| 2010-02-0207:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-007489 |
| 2010-01-1416:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-002593 |
| 2009-12-2216:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-072718 |
| 2009-12-1017:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-069612 |
| 2009-12-0107:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-067060 |
| 2009-11-0916:30 ET | 10-Q | Quarterly reportPeriod 2009-09-30 | 0000950123-09-060191 |
| 2009-10-1515:00 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-050607 |
| 2009-10-1506:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-050478 |
| 2009-09-2516:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-09-050052 |
| 2009-09-2417:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-045770 |
| 2009-09-2410:58 ET | SC 13D/A | Ownership report, active investor, amended | 0001178913-09-002261 |
| 2009-09-1819:47 ET | DEF 14A | Proxy statementPeriod 2009-11-09 | 0000950123-09-043950 |
| 2009-09-1416:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-042977 |
| 2009-09-0816:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-041654 |
| 2009-08-2616:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-038204 |
| 2009-08-1716:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-035833 |
| 2009-08-0317:29 ET | 10-Q | Quarterly reportPeriod 2009-06-30 | 0000950123-09-029006 |
| 2009-07-1410:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-022058 |
| 2009-07-0609:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-020137 |
| 2009-06-2516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-017282 |
| 2009-06-0417:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-09-011463 |
| 2009-06-0216:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-09-010496 |
| 2009-05-1116:15 ET | 10-Q | Quarterly reportPeriod 2009-03-31 | 0000950123-09-008534 |
| 2009-03-1112:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-09-004426 |
| 2009-03-0616:51 ET | 10-Q/A | Quarterly report, amendedPeriod 2008-03-31 | 0000950123-09-004208 |
| 2009-03-0616:22 ET | 10-Q/A | Quarterly report, amendedPeriod 2008-09-30 | 0000950123-09-004206 |
| 2009-03-0616:22 ET | 10-Q/A | Quarterly report, amendedPeriod 2008-06-30 | 0000950123-09-004205 |
| 2009-03-0616:06 ET | 10-K | Annual reportPeriod 2008-12-31 | 0000950123-09-004203 |
| 2009-02-2617:09 ET | 8-K | 4.02 Non-reliance on financial statements | 0000950123-09-003574 |
| 2009-02-1308:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-09-002694 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.